Effectiveness of Physician and Pharmacist Collaboration in the Focused Treatment of Obesity and Type 2 Diabetes Mellitus
Project Description: This quality improvement project is designed to improve treatment of both obesity and type 2 diabetes via cohesive collaboration between the primary care physician (PCP) and the clinical pharmacist. Specifically, the project would primarily aim to help decrease body mass index (BMI), weight (kg), and hemoglobin A1c in addition to improving core measures designated by CMS, such as patients having up-to-date urinary microalbumin tests and eye exams. Previous studies have shown that collaboration between PCPs and clinical pharmacists have improved hemoglobin A1c control, however there are no available studies that describe the impact of PCP and pharmacist collaboration in the focused treatment of obesity and diabetes. Further, a multidisciplinary approach has been recommended in national guidelines, including the 2018 ADA Standards of Care in Diabetes and the 2013 AHA/ACC/TOS Guidelines for the Management of Overweight and Obesity in Adults. This collaborative model includes a thorough initial evaluation of the patient, including a review of comorbidities, medications affecting weight, drug-drug interactions, and current diet and exercise. There will also be a discussion on the patient’s goals and financial considerations that would likely impact pharmacotherapy choice. The PCP and pharmacist would jointly decide upon a customized plan for the patient and the patient would receive extensive counseling on their new regimen. Subsequent visits would be focused on adherence, barriers, weight and blood glucose log review, insulin titration if relevant, and modification of therapies if needed. Patients would be expected to follow-up every two to four weeks. The project will be rolled out as a pilot initially, with adjustments made to the protocol if needed. If successful, as determined by a clinically significant decrease in BMI, weight, and hemoglobin A1c, it is hoped that this model could be implemented throughout the internal medicine department.
QPI: Amy, Talana, (firstname.lastname@example.org)
Collaborators: Edlira, Maska, (email@example.com); (Neal.Holland@medicine.ufl.edu); Eric, Dietrich, (firstname.lastname@example.org)
Advisors: Eric, Dietrich, (email@example.com)
UF Health Big Aims: Increase Value None
MeSH Keywords: Diabetes Mellitus, Drug Interactions, Obesity, Interdisciplinary Communication, Collaboration